Zetta Genomics Ltd

Zetta Genomics Ltd

Private
CambridgeHealthcare & Life Scienceshttps://zettagenomics.com

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$8.01M

Momentum Score

50 /100

Company Overview

Zetta Genomics Ltd is a genomic data technology company that provides the XetaBase platform for large-scale genomic data management and analysis to enable precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Database Management, Biotechnology, Platform-as-a-Service

Business Model

B2G

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Infrastructure

Keywords

genomic data platformgenomic databasebioinformatics platformpopulation-scale genomicsprecision medicinegenomics infrastructurevariant analysisreal-time queryingSaaS platformTrusted Research EnvironmentsTREsgenomic medicinePaaShealthcare analyticsOpenCB

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zetta Genomics Ltd Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Zetta Genomics Ltd Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
SeedApr 18, 2023
SeedFeb 1, 2022

Key People

Founding team and executive leadership

Ignacio Medina

Founder, CEO And CTO At Zetta Genomics

Founding Team

Bryony Burrows

Chief Operating Officer, Chief Financial Officer

Executive Team

Zetta Genomics Ltd Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Acquired key assets from UK-based healthcare technology partner Zetta Genomics.

  • Apr 8, 2025

    Named a finalist in two categories at the Seed Legals Startup Awards.

Zetta Genomics Ltd Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zetta Genomics Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zetta Genomics Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range24
Year Founded2018
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.